Skip to content
Screener

Reported February 4, 2026 · After market close

Revenue$373.9MBeat by $18.3M
EPS$0.87Beat by $0.18
Revenue estimate$355.6M
EPS estimate$0.69

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$379.4M
EPS estimate$0.77

Financials

Q2 2026

Income statement

See full
Revenue$373.9M+20.9%
Gross profit$132.7M+30.2%
Operating income$50.3M+97.1%
Net income$27.5M+762%
EPS (diluted)$0.67+738%

Balance sheet

See full
Cash & equivalents$55.5M-17.3%
Total debt$29.6M+22.0%
Total equity$332.4M+34.7%
Total assets$1.4B+9.3%

Cash flow

See full
Operating cash flow$19.4M+529%
CapEx$11.1M+41.9%
Free cash flow$8.3M+274%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.51B+78.0%
Enterprise value$1.49B+84.3%
P/E16.4×-27.6×
P/S+0.3×

Profitability

See full
Gross margin31.9%+0.1pp
Operating margin11.5%+4.2pp
Net margin6.3%+4.5pp
FCF margin3.2%+1.8pp

Returns & leverage

See full
Return on equity31.8%+24.3pp
Debt / equity0.1×0.0×
Current ratio3.1×-0.1×

Segments

By product

See full
Medicated Feed Additives And Others$202.1M+34.4%
Mineral Nutrition$68.9M+9.0%
Nutritional Specialties$50.2M+9.4%
Vaccines$37.6M+13.5%
Performance Products$15.0M-9.7%

By geography

See full
Latin America And Canada$87.6M+20.5%
EMEA$44.8M+37.4%
Asia Pacific$19.8M+1.1%

By segment

See full
Mineral Nutrition$68.9M+9.0%
Performance Products$15.0M-9.7%

FAQ

When did Phibro Animal Health Corporation report Q2 2026 earnings?
Phibro Animal Health Corporation (PAHC) reported Q2 2026 earnings on February 4, 2026 after market close.
What were Phibro Animal Health Corporation's Q2 2026 revenue and EPS?
Phibro Animal Health Corporation reported revenue of $373.9M and eps of $0.87 for Q2 2026.
Did Phibro Animal Health Corporation beat estimates in Q2 2026?
Revenue beat the consensus estimate of $355.6M by $18.3M. EPS beat the consensus estimate of $0.69 by $0.18.
How did Phibro Animal Health Corporation's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.9% from $309.3M a year earlier and eps grew 61.1% from $0.54.
Where can I find Phibro Animal Health Corporation's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-009739) and the 10-Q periodic report (0001104659-26-010317) directly on SEC EDGAR. The filing index links above go to sec.gov.